dipeptidyl peptidase-4 (dpp-4) inhibitors
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a class of medications used to treat type 2 diabetes by increasing the levels of active incretin hormones in the body. They work by blocking an enzyme called DPP-4, which breaks down these hormones. Inhibiting DPP-4 helps regulate blood sugar levels by enhancing the release of insulin and reducing the production of glucose, ultimately improving glycemic control in people with type 2 diabetes.
Requires login.
Related Concepts (1)
Similar Concepts
- alpha-glucosidase inhibitors
- dipeptidyl peptidase-4 inhibitors
- dpp-4 inhibitors
- glp-1 receptor agonists
- glucagon-like peptide-1 (glp-1)
- glucagon-like peptide-1 (glp-1) receptor agonists
- glucagon-like peptide-1 receptor agonists
- incretin mimetics
- insulin analogs
- insulin analogues
- insulin receptor antagonist
- lipase inhibitors
- sglt-2 inhibitors
- sitagliptin
- sodium-glucose cotransporter-2 inhibitors